Description: PetVivo Holdings, Inc., a biomedical device company, engages in the licensing and commercializing medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products includes 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.
Home Page: www.petvivo.com
5251 Edina Industrial Boulevard
Minneapolis,
MN
55439
United States
Phone:
952 405 6216
Officers
| Name | Title |
|---|---|
| Mr. John Lai | CEO, Pres & Director |
| Mr. Robert J. Folkes | Chief Financial Officer |
| Mr. Randall A. Meyer | Chief Operating Officer |
| Mr. Randy Wenthold | Chief Science Officer |
| Mr. John F. Dolan | Gen. Counsel, Chief Bus. Devel. Officer & Sec. |
| Mr. Gary DeMel | Exec. VP of Bus. Devel. |
| Mr. Russell Siakel | Director of Marketing |
| Mr. Mark Middleton | National Director of Sales |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.1916 |
| Price-to-Sales TTM: | 58.5547 |
| IPO Date: | 2013-05-23 |
| Fiscal Year End: | March |
| Full Time Employees: | 15 |